Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
Clinical trial NCT02968940 · COMPLETED
Trial details
- NCT number
- NCT02968940
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2019-08-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.